Yellow Fever

  • Requirements: Any traveler (except infants <6 months old) arriving by air or sea without a yellow fever vaccination certificate is detained in isolation for up to 6 days if that person—
    1. 1) arrives within 6 days of departure from an area with risk of YFV transmission,
    2. 2) has been in such an area in transit (except those passengers and members of flight crews who, while in transit through an airport in an area with risk of YFV transmission, remained in the airport during their entire stay and the health officer agrees to such an exemption),
    3. 3) arrives on a ship that started from or touched at any port in an area with risk of YFV transmission up to 30 days before its arrival in India, unless such a ship has been disinsected in accordance with the procedure recommended by WHO, or
    4. 4) arrives on an aircraft that has been in an area with risk of YFV transmission and has not been disinsected in accordance with the Indian Aircraft Public Health Rules, 1954, or as recommended by WHO.
  • The following are regarded as countries and areas with risk of YFV transmission:
  • Africa: Angola, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, South Sudan, Sudan, Togo, and Uganda.
  • Americas: Argentina, Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Panama, Paraguay, Peru, Suriname, Trinidad (Trinidad only), and Venezuela.
  • Note: When a case of yellow fever is reported from any country, that country is regarded by the government of India as a country with risk of YFV transmission and is added to the above list.
  • Recommendations: None.

Malaria

  • Areas with malaria: All areas throughout the country, including cities of Bombay (Mumbai) and Delhi, except none in areas >2,000 m (6,562 ft) in Himachal Pradesh, Jammu and Kashmir, and Sikkim (see Map 3-29).
  • Estimated relative risk of malaria for US travelers: Moderate.
  • Drug resistance 4: Chloroquine.
  • Malaria species: P. vivax 50%, P. falciparum >40%, P. malariae and P. ovale rare.
  • Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, or mefloquine.
Map 3-29. Malaria in India

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - India ID - 204298 Y1 - 2018 PB - CDC Yellow Book UR - https://relief.unboundmedicine.com/relief/view/cdc-yellow-book/204298/all/India ER -